Published in Psychopharmacology (Berl) on November 03, 2016
Attention-deficit hyperactivity disorder. Lancet (2005) 5.75
Neurotrophins and neuronal plasticity. Science (1995) 4.53
Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A (1999) 3.82
An integrative theory of attention-deficit/ hyperactivity disorder based on the cognitive and affective neurosciences. Dev Psychopathol (2005) 2.36
Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication. J Am Acad Child Adolesc Psychiatry (2013) 2.30
Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology (2007) 1.91
Gray matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. Am J Psychiatry (2011) 1.69
Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology (2001) 1.46
Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder. J Clin Psychopharmacol (2008) 1.44
Determinants of serum brain-derived neurotrophic factor. Psychoneuroendocrinology (2010) 1.40
Stimulants and the developing brain. Trends Pharmacol Sci (2005) 1.31
Further development of a neurobehavioral profile of fetal alcohol spectrum disorders. Alcohol Clin Exp Res (2012) 1.23
Maternal smoking during pregnancy is associated with epigenetic modifications of the brain-derived neurotrophic factor-6 exon in adolescent offspring. Am J Med Genet B Neuropsychiatr Genet (2010) 1.23
Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study. Pediatrics (2009) 1.20
Intense exercise increases circulating endocannabinoid and BDNF levels in humans--possible implications for reward and depression. Psychoneuroendocrinology (2011) 1.19
Epigenetic marking of the BDNF gene by early-life adverse experiences. Horm Behav (2010) 1.18
Prenatal Maternal Stress Associated with ADHD and Autistic Traits in early Childhood. Front Psychol (2011) 1.14
Deep serotonergic and dopaminergic structures in fetal alcoholic syndrome: a study with nor-beta-CIT-single-photon emission computed tomography and magnetic resonance imaging volumetry. Biol Psychiatry (2005) 1.09
Opposite effects of stimulant and antipsychotic drugs on striatal fast-spiking interneurons. Neuropsychopharmacology (2010) 1.07
Neurosteroids in the context of stress: implications for depressive disorders. Pharmacol Ther (2007) 1.05
Obesity in men with childhood ADHD: a 33-year controlled, prospective, follow-up study. Pediatrics (2013) 1.01
Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry (2008) 1.00
Pre- and postnatal risk factors for ADHD in a nonclinical pediatric population. J Atten Disord (2012) 0.97
A study of how socioeconomic status moderates the relationship between SNPs encompassing BDNF and ADHD symptom counts in ADHD families. Behav Genet (2007) 0.97
Genetic variation in brain-derived neurotrophic factor is associated with serotonin transporter but not serotonin-1A receptor availability in men. Biol Psychiatry (2009) 0.96
In utero alcohol exposure, epigenetic changes, and their consequences. Alcohol Res (2013) 0.95
Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bull (2011) 0.94
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice. Psychoneuroendocrinology (2013) 0.94
Predominance of D2 receptors in mediating dopamine's effects in brain metabolism: effects of alcoholism. J Neurosci (2013) 0.94
Sex differences in Parkinson's disease. Front Neuroendocrinol (2014) 0.92
Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice. Eur J Pharmacol (2009) 0.91
Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus. Neurosci Lett (2012) 0.91
Gender specific associations of serum levels of brain-derived neurotrophic factor in anxiety. World J Biol Psychiatry (2011) 0.90
Is altered BDNF biosynthesis a general feature in patients with cognitive dysfunctions? Neuroscientist (2012) 0.90
Synaptic regulation of affective behaviors; role of BDNF. Neuropharmacology (2013) 0.89
Sub-chronic exposure to atomoxetine up-regulates BDNF expression and signalling in the brain of adolescent spontaneously hypertensive rats: comparison with methylphenidate. Pharmacol Res (2010) 0.88
Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. Am J Med Genet B Neuropsychiatr Genet (2010) 0.87
The release of glutamate from cortical neurons regulated by BDNF via the TrkB/Src/PLC-γ1 pathway. J Cell Biochem (2013) 0.86
Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood. Front Synaptic Neurosci (2014) 0.86
Involvement of brain-derived neurotrophic factor (BDNF) in the functional elimination of synaptic contacts at polyinnervated neuromuscular synapses during development. J Neurosci Res (2010) 0.85
ADHDgene: a genetic database for attention deficit hyperactivity disorder. Nucleic Acids Res (2011) 0.85
Psychosocial dwarfism: psychopathological aspects and putative neuroendocrine markers. Psychiatry Res (2010) 0.84
Epigenetic mechanisms regulating learning and long-term memory. Int J Dev Neurosci (2012) 0.84
Body temperature, activity and melatonin profiles in adults with attention-deficit/hyperactivity disorder and delayed sleep: a case-control study. J Sleep Res (2013) 0.84
Comorbid symptom severity in attention-deficit/hyperactivity disorder: a clinical study. J Clin Psychiatry (2012) 0.84
Neurochemical and neuropharmacological aspects of circadian disruptions: an introduction to asynchronization. Curr Neuropharmacol (2011) 0.84
Dopamine D1-like receptor activation induces brain-derived neurotrophic factor protein expression. Neuroreport (2009) 0.84
Serum brain-derived neurotrophic factor (BDNF) levels in attention deficit-hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry (2013) 0.84
Attention deficit hyperactivity disorder. Curr Top Behav Neurosci (2014) 0.83
Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions. Prog Neurobiol (2013) 0.82
The search for biomarkers for attention deficit/hyperactivity disorder. Drug News Perspect (2010) 0.82
Sex-specific association of brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and plasma BDNF with attention-deficit/hyperactivity disorder in a drug-naïve Han Chinese sample. Psychiatry Res (2014) 0.81
Circadian modulation of memory and plasticity gene products in a diurnal species. Brain Res (2014) 0.81
Decreased serum levels of brain-derived neurotrophic factor in adults with attention-deficit hyperactivity disorder. Int J Neuropsychopharmacol (2013) 0.80
Association of salivary dehydroepiandrosterone levels and symptoms in patients with attention deficit hyperactivity disorder during six months of treatment with methylphenidate. Psychoneuroendocrinology (2011) 0.80
Innate BDNF expression is associated with ethanol intake in alcohol-preferring AA and alcohol-avoiding ANA rats. Brain Res (2014) 0.80
Neuronal instability: implications for Rett's syndrome. Brain Dev (2001) 0.80
The Physiology of BDNF and Its Relationship with ADHD. Mol Neurobiol (2014) 0.80
Changes in plasma Brain-derived neurotrophic factor (BDNF) levels induced by methylphenidate in children with Attention deficit-hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.79
Changes in the serum levels of brain-derived neurotrophic factor in adults with attention deficit hyperactivity disorder after treatment with atomoxetine. Psychopharmacology (Berl) (2013) 0.78
YY162 prevents ADHD-like behavioral side effects and cytotoxicity induced by Aroclor1254 via interactive signaling between antioxidant potential, BDNF/TrkB, DAT and NET. Food Chem Toxicol (2014) 0.78
Differential responses of two related neurosteroids to methylphenidate based on ADHD subtype and the presence of depressive symptomatology. Psychopharmacology (Berl) (2014) 0.78
Methylphenidate effects on blood serotonin and melatonin levels may help to synchronise biological rhythms in children with ADHD. J Psychiatr Res (2012) 0.78
The effect of dehydroepiandrosterone (DHEA) on Zucker rat food selection and hypothalamic neurotransmitters. Psychoneuroendocrinology (1997) 0.77
Effects of prenatal alcohol exposure and attention-deficit/hyperactivity disorder on adaptive functioning. Alcohol Clin Exp Res (2014) 0.77
Effect of methylphenidate treatment on appetite and levels of leptin, ghrelin, adiponectin, and brain-derived neurotrophic factor in children and adolescents with attention deficit and hyperactivity disorder. Int J Psychiatry Clin Pract (2014) 0.77
[Validation of the attention deficit hyperactivity disorder adult assessment scale (EDAH) in a teenage population]. Rev Neurol (2010) 0.76
The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins. J Mol Neurosci (2015) 0.76
Treatments and compositions for attention deficit hyperactivity disorder: a patent review. Expert Opin Ther Pat (2016) 0.76
Methylphenidate ameliorates depressive comorbidity in ADHD children without any modification on differences in serum melatonin concentration between ADHD subtypes. Int J Mol Sci (2014) 0.75